TORONTO, – Wednesday, February 17, 2010

Chris Carl, CEO, BioExx Specialty Proteins Ltd. and Ungad Chadda, Senior Vice President, Toronto Stock Exchange, TMX Group opened the market today.  BioExx is an industrial processing company using patented technology to extract oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.  BioExx ranked number one in the Clean Technology sector on the 2010 TSX Venutre 50.  BioExx trades on Toronto Stock Exchange under the stock symbol BXI. 




About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. 

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds.  Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work.  It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others.  Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace. 

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. 

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com 

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx’s products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx’s  plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx’s expectations and projections.

FOR FURTHER INFORMATION PLEASE CONTACT: 
 
BioExx Specialty Proteins Ltd.:
Chris Schnarr
Chief Financial Officer
 (416) 588-4442 x111
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

or

Investor Relations:
Brisco Capital Partners
Scott Koyich
President
 (403) 262-9888
This e-mail address is being protected from spambots. You need JavaScript enabled to view it